Treatment of ocular allergies: nonpharmacologic, pharmacologic and immunotherapy

Research output: Contribution to journalArticle

Abstract

Ocular allergy is a significant and growing issue worldwide but for many patients, it is often not differentiated from systemic conditions, such as hay fever. Management of seasonal and perennial allergic conjunctivitis is often poor. Management is principally through avoidance measures (blocking or hygiene), nonpharmaceutical (such as artificial tears and cold compresses) and pharmaceutical (such as topical antihistamines and prophylactic mast cell stabilizers). Vernal and atopic keratoconjunctivitis are more severe and generally need treatment with NSAIDs, steroids and immunomodulators. Giant papillary conjunctivitis can be related to allergy but also is often contact lens related and in such cases can be managed by a period of abstinence and replacement of the lens or a change in lens material and/or design. Immunotherapy can be efficacious in severe, persistent cases of contact lens or allergic conjunctivitis.
LanguageEnglish
Pages257-266
Number of pages10
JournalExpert Review of Ophthalmology
Volume10
Issue number3
Early online date12 Apr 2015
DOIs
Publication statusPublished - 2015

Fingerprint

Contact lenses
Allergies
Allergic Conjunctivitis
Immunotherapy
Lenses
Hypersensitivity
Contact Lenses
Drug products
Seasonal Allergic Rhinitis
Histamine Antagonists
Immunologic Factors
Non-Steroidal Anti-Inflammatory Agents
Therapeutics
Hygiene
Mast Cells
Steroids
Pharmaceutical Preparations

Keywords

  • antihistamine
  • atopic keratoconjunctivitis
  • giant papillary conjunctivitis
  • immunotherapy
  • mast cell stabilizer
  • ocular allergy
  • perennial allergic conjunctivitis
  • seasonal allergic conjunctivitis
  • vernal keratoconjunctivitis

Cite this

@article{94cb2d3ac6fd46d9be3054897efd5910,
title = "Treatment of ocular allergies: nonpharmacologic, pharmacologic and immunotherapy",
abstract = "Ocular allergy is a significant and growing issue worldwide but for many patients, it is often not differentiated from systemic conditions, such as hay fever. Management of seasonal and perennial allergic conjunctivitis is often poor. Management is principally through avoidance measures (blocking or hygiene), nonpharmaceutical (such as artificial tears and cold compresses) and pharmaceutical (such as topical antihistamines and prophylactic mast cell stabilizers). Vernal and atopic keratoconjunctivitis are more severe and generally need treatment with NSAIDs, steroids and immunomodulators. Giant papillary conjunctivitis can be related to allergy but also is often contact lens related and in such cases can be managed by a period of abstinence and replacement of the lens or a change in lens material and/or design. Immunotherapy can be efficacious in severe, persistent cases of contact lens or allergic conjunctivitis.",
keywords = "antihistamine, atopic keratoconjunctivitis, giant papillary conjunctivitis, immunotherapy, mast cell stabilizer, ocular allergy, perennial allergic conjunctivitis, seasonal allergic conjunctivitis, vernal keratoconjunctivitis",
author = "Paramdeep Bilkhu and Shehzad Naroo and James Wolffsohn",
year = "2015",
doi = "10.1586/17469899.2015.1036031",
language = "English",
volume = "10",
pages = "257--266",
journal = "Expert Review of Ophthalmology",
issn = "1746-9899",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Treatment of ocular allergies

T2 - Expert Review of Ophthalmology

AU - Bilkhu, Paramdeep

AU - Naroo, Shehzad

AU - Wolffsohn, James

PY - 2015

Y1 - 2015

N2 - Ocular allergy is a significant and growing issue worldwide but for many patients, it is often not differentiated from systemic conditions, such as hay fever. Management of seasonal and perennial allergic conjunctivitis is often poor. Management is principally through avoidance measures (blocking or hygiene), nonpharmaceutical (such as artificial tears and cold compresses) and pharmaceutical (such as topical antihistamines and prophylactic mast cell stabilizers). Vernal and atopic keratoconjunctivitis are more severe and generally need treatment with NSAIDs, steroids and immunomodulators. Giant papillary conjunctivitis can be related to allergy but also is often contact lens related and in such cases can be managed by a period of abstinence and replacement of the lens or a change in lens material and/or design. Immunotherapy can be efficacious in severe, persistent cases of contact lens or allergic conjunctivitis.

AB - Ocular allergy is a significant and growing issue worldwide but for many patients, it is often not differentiated from systemic conditions, such as hay fever. Management of seasonal and perennial allergic conjunctivitis is often poor. Management is principally through avoidance measures (blocking or hygiene), nonpharmaceutical (such as artificial tears and cold compresses) and pharmaceutical (such as topical antihistamines and prophylactic mast cell stabilizers). Vernal and atopic keratoconjunctivitis are more severe and generally need treatment with NSAIDs, steroids and immunomodulators. Giant papillary conjunctivitis can be related to allergy but also is often contact lens related and in such cases can be managed by a period of abstinence and replacement of the lens or a change in lens material and/or design. Immunotherapy can be efficacious in severe, persistent cases of contact lens or allergic conjunctivitis.

KW - antihistamine

KW - atopic keratoconjunctivitis

KW - giant papillary conjunctivitis

KW - immunotherapy

KW - mast cell stabilizer

KW - ocular allergy

KW - perennial allergic conjunctivitis

KW - seasonal allergic conjunctivitis

KW - vernal keratoconjunctivitis

UR - http://www.scopus.com/inward/record.url?scp=84929740755&partnerID=8YFLogxK

U2 - 10.1586/17469899.2015.1036031

DO - 10.1586/17469899.2015.1036031

M3 - Article

VL - 10

SP - 257

EP - 266

JO - Expert Review of Ophthalmology

JF - Expert Review of Ophthalmology

SN - 1746-9899

IS - 3

ER -